33 |
bAb0164-BB |
Anti-EGFRvIII [L8A4] |
5 mg |
支 |
107040.00 |
34 |
bAb0164 |
Anti-EGFRvIII [L8A4] |
50 μg |
支 |
4800.00 |
35 |
bAb0163-BT |
Anti-EGFR [C225 (Cetuximab)] |
500 μg |
支 |
24720.00 |
36 |
bAb0163-BS |
Anti-EGFR [C225 (Cetuximab)] |
1 mg |
支 |
45060.00 |
37 |
bAb0163-BB |
Anti-EGFR [C225 (Cetuximab)] |
5 mg |
支 |
107040.00 |
38 |
bAb0163 |
Anti-EGFR [C225 (Cetuximab)] |
50 μg |
支 |
4800.00 |
39 |
bAb0162-BT |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
500 μg |
支 |
24720.00 |
40 |
bAb0162-BS |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
1 mg |
支 |
45060.00 |
41 |
bAb0162-BB |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
5 mg |
支 |
107040.00 |
42 |
bAb0162 |
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] |
50 μg |
支 |
4800.00 |
43 |
bAb0161-BT |
Anti-Fluorescein [4-4-20 (enhanced)] |
500 μg |
支 |
24720.00 |
44 |
bAb0161-BS |
Anti-Fluorescein [4-4-20 (enhanced)] |
1 mg |
支 |
45060.00 |
45 |
bAb0161-BB |
Anti-Fluorescein [4-4-20 (enhanced)] |
5 mg |
支 |
107040.00 |
46 |
bAb0161 |
Anti-Fluorescein [4-4-20 (enhanced)] |
50 μg |
支 |
4800.00 |
47 |
bAb0136-BT |
Anti-TRP-1, gp75 [TA99] |
500 μg |
支 |
24720.00 |
48 |
bAb0136-BS |
Anti-TRP-1, gp75 [TA99] |
1 mg |
支 |
45060.00 |